Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6U6K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,838
Award facts
- Contract value 100% obligated
- $9,837.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $9,837.60 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on December 11, 2025, with a completion date of December 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a prescription immunosuppressant used primarily for rheumatoid arthritis and other inflammatory conditions, reflecting the company's role as a critical pharmaceutical supplier for federal healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to fulfill federal medical procurement requirements competitively, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles supporting the broader Defense Logistics Agency medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F6U6K?
SPE2DR26F6U6K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26F6U6K worth?
The government has obligated $9,838 on SPE2DR26F6U6K.
Is contract SPE2DR26F6U6K an order under another contract?
Yes. SPE2DR26F6U6K is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6U6K competed?
The extent of competition for SPE2DR26F6U6K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award